ClinConnect ClinConnect Logo
Search / Trial NCT03222544

Clinical Study of Methylene Blue - Mediated Photodynamic Therapy for Diabetic Lower Limb Ulcer

Launched by CHONGQING MEDICAL UNIVERSITY · Jul 17, 2017

Trial Information

Current as of May 29, 2025

Unknown status

Keywords

Methylene Blue Photodynamics Therapy

ClinConnect Summary

OBJECTIVE- Infection is associated with poor healing of diabetic lower limb ulcer. Diabetic lower limb ulcer are often lower extremity vascular stenosis or occlusion, poor blood supply, making local ulcer local antibacterial drugs difficult to effectively reach and distribution, resulting in systemic antibacterial efficacy is limited, and easy to induce bacterial resistance at the same time . In recent years, the incidence of clinical multidrug-resistant bacteria increased, increasing the difficulty and cost of treatment.

The current study attempts to identify whether the photodynamic ther...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Understand the whole test process, voluntary and signed informed consent form.
  • 2. Men and women aged 18 to 80 years old.
  • 3. Diagnosed with diabetic lower limb ulcer.
  • 4. Ulcer duration\> 1 month of wagner grade Ⅱ, Ⅲ subjects.
  • 5. An ulcer area ≤100 cm² or of linear dimension ≤ 10 cm.
  • Exclusion Criteria:
  • 1. Diagnosis of systemic infection or any concomitant infection that would require treatment with an additional antimicrobial agent.
  • 2. Pregnant or lactating women.
  • 3. Wagner grade Ⅰ, Ⅳ, Ⅴ subjects.
  • 4. Patients with a peripheral vascular disease require immediate revascularization, and/or an ankle brachial systolic blood pressure (SBP) index\<0.5 in the infected limb.
  • 5. Patients with inappropriate health to participate as determined by the principal investigators.
  • 6. Patients in the hepatitis A, hepatitis B, AIDS, tuberculosis and other infectious diseases of the active period.

About Chongqing Medical University

Chongqing Medical University is a prestigious institution dedicated to advancing medical education, research, and healthcare innovation. As a leading clinical trial sponsor, the university is committed to conducting rigorous clinical research that adheres to the highest ethical standards and regulatory guidelines. With a strong focus on improving patient outcomes and contributing to scientific knowledge, Chongqing Medical University leverages its comprehensive resources, including a diverse faculty of experts and state-of-the-art facilities, to facilitate groundbreaking studies across various medical disciplines. Through its collaborative approach, the university aims to foster partnerships that enhance the translation of research findings into clinical practice.

Locations

Chongqing, , China

Patients applied

0 patients applied

Trial Officials

Qingfeng Cheng, PhD

Principal Investigator

the First Affiliated Hospital, Chongqing Medical University, China

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials